191 related articles for article (PubMed ID: 24123035)
1. Preoperative neutrophil-to-lymphocyte ratio predicts clinical outcome in patients with stage II and III colon cancer.
Absenger G; Szkandera J; Stotz M; Postlmayr U; Pichler M; Ress AL; Schaberl-Moser R; Loibner H; Samonigg H; Gerger A
Anticancer Res; 2013 Oct; 33(10):4591-4. PubMed ID: 24123035
[TBL] [Abstract][Full Text] [Related]
2. The elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patients.
Szkandera J; Pichler M; Absenger G; Stotz M; Arminger F; Weissmueller M; Schaberl-Moser R; Samonigg H; Kornprat P; Stojakovic T; Avian A; Gerger A
Am J Surg; 2014 Aug; 208(2):210-4. PubMed ID: 24581872
[TBL] [Abstract][Full Text] [Related]
3. [An elevated neutrophil/lymphocyte ratio is associated with poor prognosis in stage II resected colon cancer].
Urrejola GI; Bambs CE; Espinoza MA; Gellona J; Zúñiga AM; Molina ME; Bellolio F; Miguieles R; Campbell JM; Pinedo GA
Rev Med Chil; 2013 May; 141(5):602-8. PubMed ID: 24089275
[TBL] [Abstract][Full Text] [Related]
4. The preoperative neutrophil-lymphocyte ratio predicts recurrence and survival among patients undergoing R0 resections of adenocarcinomas of the esophagogastric junction.
Yuan D; Zhu K; Li K; Yan R; Jia Y; Dang C
J Surg Oncol; 2014 Sep; 110(3):333-40. PubMed ID: 24889121
[TBL] [Abstract][Full Text] [Related]
5. Effect of hypertension on preoperative neutrophil-lymphocyte ratio evaluation of prognosis of renal cell carcinoma.
Sun J; Ning H; Sun J; Qu X
Urol Oncol; 2016 May; 34(5):239.e9-15. PubMed ID: 26803433
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus.
Toh E; Wilson J; Sebag-Montefiore D; Botterill I
Colorectal Dis; 2014 Mar; 16(3):O90-7. PubMed ID: 24148256
[TBL] [Abstract][Full Text] [Related]
7. Preoperative neutrophil-lymphocyte ratio as an independent prognostic marker for patients with upper urinary tract urothelial carcinoma.
Azuma T; Matayoshi Y; Odani K; Sato Y; Sato Y; Nagase Y; Oshi M
Clin Genitourin Cancer; 2013 Sep; 11(3):337-41. PubMed ID: 23665132
[TBL] [Abstract][Full Text] [Related]
8. Elevated preoperative neutrophil-to-lymphocyte ratio predicts poor disease-free survival in Chinese women with breast cancer.
Hong J; Mao Y; Chen X; Zhu L; He J; Chen W; Li Y; Lin L; Fei X; Shen K
Tumour Biol; 2016 Mar; 37(3):4135-42. PubMed ID: 26490984
[TBL] [Abstract][Full Text] [Related]
9. A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients.
Absenger G; Szkandera J; Pichler M; Stotz M; Arminger F; Weissmueller M; Schaberl-Moser R; Samonigg H; Stojakovic T; Gerger A
Br J Cancer; 2013 Jul; 109(2):395-400. PubMed ID: 23820252
[TBL] [Abstract][Full Text] [Related]
10. Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board.
Kao SC; Vardy J; Chatfield M; Corte P; Pavlakis N; Clarke C; van Zandwijk N; Clarke S
Clin Lung Cancer; 2013 Jan; 14(1):70-7. PubMed ID: 22658812
[TBL] [Abstract][Full Text] [Related]
11. Novel immunological and nutritional-based prognostic index for gastric cancer.
Sun KY; Xu JB; Chen SL; Yuan YJ; Wu H; Peng JJ; Chen CQ; Guo P; Hao YT; He YL
World J Gastroenterol; 2015 May; 21(19):5961-71. PubMed ID: 26019461
[TBL] [Abstract][Full Text] [Related]
12. A high preoperative neutrophil-to-lymphocyte ratio is associated with poor survival in patients with colorectal cancer.
Shibutani M; Maeda K; Nagahara H; Noda E; Ohtani H; Nishiguchi Y; Hirakawa K
Anticancer Res; 2013 Aug; 33(8):3291-4. PubMed ID: 23898094
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy.
Gondo T; Nakashima J; Ohno Y; Choichiro O; Horiguchi Y; Namiki K; Yoshioka K; Ohori M; Hatano T; Tachibana M
Urology; 2012 May; 79(5):1085-91. PubMed ID: 22446338
[TBL] [Abstract][Full Text] [Related]
14. [Predicting value of dynamic alteration of blood neutrophil/lymphocyte ratio on recurrence-free survival in patients with advanced colon cancer after operation and chemotherapy].
Li J; Jia YB; Cai CN; Guan XD; Li PP; Xie YY; Zhang BM
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Nov; 15(11):1171-4. PubMed ID: 23172532
[TBL] [Abstract][Full Text] [Related]
15. Pre-treatment neutrophil to lymphocyte ratio is a predictor of prognosis in endometrial cancer.
Haruma T; Nakamura K; Nishida T; Ogawa C; Kusumoto T; Seki N; Hiramatsu Y
Anticancer Res; 2015 Jan; 35(1):337-43. PubMed ID: 25550569
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of neutrophil to lymphocyte ratio in patients with gallbladder carcinoma.
Zhang L; Wang R; Chen W; Xu X; Dong S; Fan H; Liu C
HPB (Oxford); 2016 Jul; 18(7):600-7. PubMed ID: 27346141
[TBL] [Abstract][Full Text] [Related]
17. Significance of the preoperative neutrophil-to-lymphocyte ratio in the prognosis of patients with gastric cancer.
Yu L; Lv CY; Yuan AH; Chen W; Wu AW
World J Gastroenterol; 2015 May; 21(20):6280-6. PubMed ID: 26034363
[TBL] [Abstract][Full Text] [Related]
18. [Impact of neutrophil-to-lymphocyte ratio on the prognosis of patients with locally advanced colorectal cancer].
Jiang H; Wang H; Li A; Tang E; Chen Y; Wang A; Deng X; Lin M
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):550-554. PubMed ID: 28534334
[TBL] [Abstract][Full Text] [Related]
19. Is the pretreatment neutrophil to lymphocyte ratio an important prognostic parameter in patients with metastatic renal cell carcinoma?
Cetin B; Berk V; Kaplan MA; Afsar B; Tufan G; Ozkan M; Isikdogan A; Benekli M; Coskun U; Buyukberber S
Clin Genitourin Cancer; 2013 Jun; 11(2):141-8. PubMed ID: 23083797
[TBL] [Abstract][Full Text] [Related]
20. Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients.
Pistelli M; De Lisa M; Ballatore Z; Caramanti M; Pagliacci A; Battelli N; Ridolfi F; Santoni M; Maccaroni E; Bracci R; Santinelli A; Biscotti T; Berardi R; Cascinu S
BMC Cancer; 2015 Mar; 15():195. PubMed ID: 25884918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
